companydata.dkcompanydata.dk

MEJLGAARD INVEST ApS: Financial statements 2023

CVR: 10042933

Source: annual report 2023, Danish Business Authority

01/05/2022 – 30/04/2023

MEJLGAARD INVEST ApS (CVR 10042933) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -35,584 and a net result of DKK 99,498 compared with DKK -493,634 the year before. Equity in the 2023 report amounted to DKK 16,267,957. The solvency ratio was 99.8%.

Revenue
DKK 0
Gross Profit
DKK -35,584
Profit/Loss
DKK 99,498
Equity
DKK 16,267,957
Total Assets
DKK 16,296,957
Employees
0

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
20230-36K99K16.3M0
2022--48K-494K16.3M1
2021--46K3.7M16.9M1
2020--40K1.2M13.3M1
2019--48K1.7M12.2M1

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.

See the API documentation

About MEJLGAARD INVEST ApS

MEJLGAARD INVEST ApS was a Danish company of the type Anpartsselskab based in Hellerup, founded in 1985. The company has been dissolved on 3 September 2024. The company was registered under the industry Virksomhedsrådgivning og anden rådgivning om driftsledelse. The company was previously named S.M.J. PHARMA AF 1/10 85 ApS. The company has 1 employee (2023). In 2023, the company reported a gross profit of DKK -35,584 and a net result of DKK 99,498 compared with DKK -493,634 the year before. Equity in the 2023 report amounted to DKK 16,267,957.

Source: annual report 2023, Danish Business Authority